tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

BetterLife announces debt conversions

BetterLife (BETRF) Pharma has issued 642,329 common shares and 642,329 share purchase warrants pursuant to the conversion option of convertible debentures and accrued interest on convertible debentures totaling $64,232.88. Share purchase warrants are exercisable into common shares, on a one-for-one basis, at an exercise price of $0.10 per warrant and expire on September 27, 2026 and October 29, 2026.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1